News coverage about Colgate-Palmolive (NYSE:CL) has trended somewhat positive recently, according to Accern Sentiment Analysis. The research firm scores the sentiment of news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Colgate-Palmolive earned a daily sentiment score of 0.04 on Accern’s scale. Accern also assigned news stories about the company an impact score of 47.4435042894747 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

These are some of the media headlines that may have impacted Accern Sentiment’s scoring:

Colgate-Palmolive (NYSE:CL) traded up $0.11 during mid-day trading on Tuesday, hitting $70.30. 3,373,435 shares of the company traded hands, compared to its average volume of 4,390,000. The company has a debt-to-equity ratio of 24.42, a quick ratio of 0.34 and a current ratio of 0.47. Colgate-Palmolive has a 1-year low of $67.19 and a 1-year high of $77.91. The firm has a market cap of $61,730.00, a price-to-earnings ratio of 30.83, a PEG ratio of 2.58 and a beta of 0.75.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, January 26th. The company reported $0.75 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.75. Colgate-Palmolive had a net margin of 13.10% and a return on equity of 1,716.69%. The business had revenue of $3.89 billion during the quarter, compared to analyst estimates of $3.92 billion. During the same quarter in the previous year, the business earned $0.75 EPS. Colgate-Palmolive’s quarterly revenue was up 4.6% compared to the same quarter last year. sell-side analysts anticipate that Colgate-Palmolive will post 3.18 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, February 15th. Investors of record on Tuesday, January 23rd will be paid a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 2.28%. The ex-dividend date is Monday, January 22nd. Colgate-Palmolive’s payout ratio is presently 70.18%.

Several equities analysts have recently commented on CL shares. Zacks Investment Research upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $81.00 price target on the stock in a report on Monday, October 23rd. Deutsche Bank started coverage on shares of Colgate-Palmolive in a report on Wednesday, December 13th. They set a “hold” rating and a $75.00 price target on the stock. Jefferies Group lowered their price target on shares of Colgate-Palmolive from $79.00 to $76.00 and set a “hold” rating on the stock in a report on Monday, October 30th. Stifel Nicolaus set a $73.00 price target on shares of Colgate-Palmolive and gave the company a “hold” rating in a report on Sunday, October 29th. Finally, KeyCorp restated a “hold” rating on shares of Colgate-Palmolive in a report on Monday, October 16th. Three investment analysts have rated the stock with a sell rating, eleven have given a hold rating and five have given a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average target price of $77.71.

In other Colgate-Palmolive news, Vice Chairman Franck J. Moison sold 142,979 shares of the business’s stock in a transaction on Tuesday, February 6th. The shares were sold at an average price of $70.09, for a total transaction of $10,021,398.11. Following the completion of the transaction, the insider now owns 224,027 shares of the company’s stock, valued at approximately $15,702,052.43. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Ellen M. Hancock sold 4,676 shares of the business’s stock in a transaction on Wednesday, January 31st. The stock was sold at an average price of $74.12, for a total transaction of $346,585.12. Following the transaction, the director now directly owns 208,063 shares of the company’s stock, valued at approximately $15,421,629.56. The disclosure for this sale can be found here. In the last ninety days, insiders sold 406,869 shares of company stock valued at $29,040,662. 1.02% of the stock is owned by company insiders.

TRADEMARK VIOLATION WARNING: This piece was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece on another publication, it was illegally copied and republished in violation of United States & international copyright and trademark law. The legal version of this piece can be accessed at https://www.thecerbatgem.com/2018/02/13/colgate-palmolive-cl-getting-somewhat-positive-press-coverage-analysis-shows.html.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Insider Buying and Selling by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.